Skip to main content
A phase 2 randomized trial of a rifapentine plus moxifloxacin-based regimen for treatment of pulmonary tuberculosis
Published Web Location
http://europepmc.org/articles/PMC4861335?pdf=renderNo data is associated with this publication.
Abstract
© 2016 Conde et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.B
Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.